Maiwald Magazine

News and Releases

Maiwald Blog

9 Dec 2025 - Maiwald Blog

New fee schedule for the Unified Patent Court (UPC) from 1 January 2026

The Administrative Committee of the UPC has decided on a comprehensive reform of court fees, which will come into force on 1 January 2026. The adjustment affects almost all fe...

Continue reading

4 Nov 2025 - Maiwald Blog

Why Patent Defense and Military Technologies?

When developing high-tech technologies for use in defense and military applications, you might wonder whether patent protection is necessary. Even though your customer base is...

Continue reading

26 May 2025 - Maiwald Blog

Turn one into several – what Rule 80 EPC says about using several independent claims to defend one independent claim

The Board of Appeal of the EPO has issued two decisions concerning appeal cases T 0123/22 and T 1191/22, which relate to the interpretation of Rule 80 EPC. The fundamental que...

Continue reading

All articles

Press Coverage

5 Dec 2025 - Press Coverage

Royalty Pharma and Denali Therapeutics Announce $275 Million Royalty Funding Agreement.

Royalty Pharma and Denali have entered into a $275 million financing agreement which, pursuant to a synthetic royalty agreement, is based on future net sales of tividenofusp alfa. Tividenofusp alfa is Denali’s lead investigational TransportVehicle™-enabled enzyme rep...

Continue reading

25 Aug 2025 - Press Coverage

Royalty Pharma acquires licence interest for Amgen’s Imdelltra – Maiwald advises on transaction

Royalty Pharma has acquired a royalty interest in Amgen's Imdelltra, an innovative BiTE antibody for the treatment of small cell lung cancer, from BeOne Medicines for an upfront payment of $885 million. The agreement allows BeOne to sell additional royalty rights in Imdelltr...

Continue reading

14 Jul 2025 - Press Coverage

Royalty Pharma and Revolution Medicines Sign Funding Agreements Worth Up to $2 Billion

Royalty Pharma plc and Revolution Medicines, Inc. have announced a strategic funding collaboration of up to $2 billion to support the global development and commercialization of Revolution’s RAS(ON) inhibitor portfolio, particularly the clinical advancement of lead candida...

Continue reading

Maiwald in the press

Staff News

2 Mar 2026 - Staff News

Maiwald appoints Dr. Kerstin Wolff as Partner

Maiwald, one of Germany’s leading intellectual property law firms, has appointed Dr. Kerstin Wolff as Partner effective from 1 March 2026. This appointment further strengthe...

Continue reading

29 Jan 2026 - Staff News

Maiwald appoints Martina Boidol, Dr. Anja Fux, and Sebastian Herzog as managing partners

With retroactive effect from the beginning of the new year, Maiwald, one of Germany's leading intellectual property law firms, has appointed Martina Boidol, Dr. Anja Fux, and ...

Continue reading

11 Nov 2025 - Staff News

Dr Iris Müller and Dr Gabriel Kiefl sworn in as German patent attorneys

We are pleased to announce that our colleagues

Continue reading

All Staff News

Publications

12 Mar 2026 - Publication

Podcast: „From idea to IP: navigating AI patents in a fast-moving field“

New podcast: “From idea to IP: navigating AI patents in a fast-moving field” How can AI inventions be successfully pat...

Continue reading

4 Mar 2026 - Publication

G 2/24 in a nutshell: EBoA clarifies intervener status in EPC appeals

In G 2/24, the EPO’s Enlarged Board of Appeal confirmed that an intervener in EPC appeal proceedings remains a dependent party and cannot continue the case after all appeals...

Continue reading

11 Feb 2026 - Publication

EU provisionally approves framework for new genomic technique plants from 2028

EU member states and the European Parliament have provisionally agreed a new regulatory framework for plants produced by new genomic techniques (NGTs). The deal creates two pa...

Continue reading

All publications

Awards

12 Mar 2026 - Award

Maiwald recognized by FOCUS as a Top Medium-Sized Employer 2026

At Maiwald, we continuously strive to create a work environment where all colleagues feel welcome—with a clear focus on feedback, development, and positive collaboration. We...

Continue reading

19 Feb 2026 - Award

Chambers Germany 2026 Rankings

We are proud that Chambers & Partners has once again recognized Maiwald in its Germany 2026 guide — with

Continue reading

19 Feb 2026 - Award

Managing IP EMEA Awards 2026: shortlists revealed

The shortlist for the Managing IP EMEA Awards 2026 has been released, recognizing the region’s leading firms and practitioners for outstanding achievements in intellectual p...

Continue reading

All awards

Events

Wed.

18

18 Mar 2026 |Upcoming

Maiwald at the 2026 IPOwners Spring Summit | March 18-19th

Maiwald will participate in the 2026 IPOwners Spring Summit™ in Washington, DC, and looks forward to engaging with IP professionals from across the in-house and private‑practice community. We are pleased that our colleagues Dr. Michaela Weigel-Krusemarck and Dr. Derk Vos will be on site. The one‑day conference, hel...

Continue reading

Wed.

8

8 Apr 2026 |Upcoming

Maiwald at the 33rd Annual IP Conference of the Fordham IP Institute in New York

The 33rd Annual IP Law & Policy Conference of the renowned Fordham Intellectual Property Institute will take place from 8 to 10 April 2026 at Fordham Law School in New York. This event brings together leaders from government, the judiciary, academia and business worldwide to discuss current challenges in intellectual property.

Continue reading

Sun.

26

26 Apr 2026 |Upcoming

LESI 2026 Annual Conference in Dublin | April 26th-29th

Maiwald will once again participate in the LESI Annual Conference in 2026. “LESI 2026 – INNOVATION TO IMPACT: IP as an International Growth Engine” will take place on 26–29 April and will bring together leading minds and decision-makers in Dublin to showcase how intellectual property serves as an...

Continue reading

Wed.

29

29 Apr 2026 |Upcoming|External Events

Maiwald at LSPN North America Spring 2026 in Boston | April 29th-30th

Maiwald will once again participate in the most influential IP conference for the life sciences this year. The annual LSPN Spring conference in Boston is a key meeting point for cutting-edge insights into IP challenges across the pharmaceutical, biotechnology, and medical device industries. We are theref...

Continue reading

All events